News
The Latest Industry News
The History of Metformin
Posted on September 18, 2017Metformin is one of the most commonly used medications in endocrinology. It is the preferred first-line oral blood glucose-lowering medicine to manage type 2 diabetes. It is also used in the treatment of polycystic ovary syndrome. Sometimes it is used, along with other medications, to treat infertility. The journal Diabetologia dedicated a special issue this […]
Read More
New Medication Option for Osteoporosis Treatment
Posted on July 17, 2017The Food and Drug Administration (FDA) has approved Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture. High risk for fracture is defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with […]
Read More
New technology is “game changer” for patients with Type 1 diabetes
Posted on June 9, 2017See the segment on Fox 7 News featuring Texas Diabetes & Endocrinology founder Thomas Blevins, MD for more information on this exciting new technology! http://www.fox7austin.com/good-day/257839964-story
Read More
One of world’s most prestigious endocrinology conferences comes to Austin!
Posted on May 19, 2017Texas Diabetes & Endocrinology was excited about one the world’s largest endocrinology conferences being in Austin this year. The Annual Scientific & Clinical Congress of the American Association of Clinical Endocrinologists was held in Downtown Austin between May 3rd and 7th. This is a world-renowned meeting which highlights the latest technological and medical advances in […]
Read MorePOSTS BY TOPIC
